Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing
Nia JulianDecember 21, 2023
Facebook0 Twitter Pinterest0 0 Likes
Previous

Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis

Nia JulianFebruary 15, 2024
Next

Arcellx and Kite Announce Expansion In Strategic Partnership

Nia JulianNovember 15, 2023

© 2020 Solasta Ventures. All Rights Reserved.